Positive Results Announced in Largest Pivotal Phase 3 Trial of a First-in-Class Oral Antibiotic Zoliflodacin to Treat Uncomplicated Gonorrhea

A Phase 3 study of oral zoliflodacin met the primary endpoint when compared against the combination of injectable ceftriaxone and oral azithromycin, a current international standard of care. Positive top-line study results are a significant...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials